tiprankstipranks
Trending News
More News >
Medexus Pharmaceuticals Inc (TSE:MDP)
TSX:MDP
Canadian Market
Advertisement

Medexus Pharmaceuticals Inc (MDP) Income Statement

Compare
59 Followers

Medexus Pharmaceuticals Inc Income Statement

Last quarter (Q4 2024), Medexus Pharmaceuticals Inc's total revenue was $24.75M, a decrease of -4.65% from the same quarter last year. In Q4, Medexus Pharmaceuticals Inc's net income was $-553.00K. See Medexus Pharmaceuticals Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
$ 108.33M$ 113.05M$ 108.10M$ 76.70M$ 79.66M
Gross Profit
$ 56.58M$ 59.51M$ 60.04M$ 37.93M$ 42.01M
Operating Expenses
$ 48.36M$ 48.72M$ 52.42M$ 52.92M$ 41.27M
Depreciation and Amortization
$ 7.18M$ 5.81M$ 8.05M$ 7.40M$ 7.90M
EBITDA
$ 16.81M$ 19.28M$ 16.14M$ 15.16M$ -23.61M
Operating Income
$ 8.22M$ 10.79M$ 7.61M$ -15.00M$ -1.38M
Other Income/Expenses
$ -6.78M$ -10.69M$ -12.65M$ 11.18M$ -30.13M
Pretax Income
$ 1.44M$ 106.00K$ -5.04M$ -3.82M$ -31.50M
Net Income
$ 2.25M$ -214.00K$ 1.22M$ -2.88M$ -28.26M
Per Share Metrics
Basic EPS
$ 0.09$ -0.01$ 0.08$ -0.19$ -2.34
Diluted EPS
$ 0.08$ -0.01$ 0.08$ -0.19$ -2.34
Weighted Average Shares Outstanding
25.82M 22.32M 19.98M 19.45M 15.20M
Weighted Average Shares Outstanding (Diluted)
26.51M 22.49M 20.52M 19.86M 15.20M
Currency in USD

Medexus Pharmaceuticals Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis